You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
2011, Volume 18 Issue 04, pages 145-192
CLINICAL ARTICLE
Br J Cardiol 2011;18:167–69
Drugs for diabetes: part 6 GLP-1 receptor agonists
The glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of injected drugs for the treatment of type 2 diabetes. They mimic the action of
CLINICAL ARTICLE
Br J Cardiol 2011;18:171–76
MyAction: an innovative approach to the prevention of cardiovascular disease in the community
We developed and piloted an innovative family-centred preventive cardiology programme (MyAction) that aimed to both integrate the care of patients with vascular disease with that
CLINICAL ARTICLE
Br J Cardiol 2011;18:178
Lifestyle advice and drug therapy post-myocardial infarction: a survey of UK current practice
Reducing morbidity and mortality among post-myocardial infarction (MI) patients requires the implementation of effective secondary measures. This survey examined current practice by assessing the view
CLINICAL ARTICLE
Br J Cardiol 2011;18:179
Ranolazine in the management of chronic stable angina
Ranolazine has been evaluated in three trials in patients with stable angina (MARISA, CARISA and ERICA) and one large trial of patients with non-ST elevation
CLINICAL ARTICLE
Br J Cardiol 2011;18:180–84
Community-based cardiovascular risk reduction: age and the Framingham risk score
This study examined the effect of a community-based intervention on the natural rise with age of the Framingham 10-year risk score. Patients in the 45–64-year-old
CLINICAL ARTICLE
Br J Cardiol 2011;18:185–88
Implementation of the new NICE guidelines for stable chest pain: likely impact on chest pain services in the UK
National Institute for Health and Clinical Excellence (NICE) guidelines for the management of chest pain suggest a care pathway based on symptoms and clinical risk,
EDITORIAL
Br J Cardiol 2011;18:149–51
Academic clinical trials – exaggerated reports of their death
Modern medical practice calls for an evidence-based approach. The best medicine is, therefore, built on a foundation of the best evidence. The best evidence, in
NEWS
Br J Cardiol 2011;18:153-154
Latest news from the world of cardiology
NHS Improvement: what is the future for heart and stroke services?
On the eve of his retirement, the outgoing National Director for Heart Disease and Stroke,
MEETING REPORT
Br J Cardiol 2011;18:158–9
Old problems, new solutions: the HEART UK annual conference
HEART UK – The Cholesterol Charity held its 25th annual conference at Warwick University from 6th-8th July 2011, entitled ‘Partners in Prevention - Lipids in
BOOK REVIEW
Br J Cardiol 2011;18:160
Book reviews
Manual of perioperative care in adult cardiac surgery, 5th edition
Author: Bojar, RM Publisher: Wiley-Blackwell, 2010 ISBN: 978-1-4443-3143-1 Price:
NEWS
Br J Cardiol 2011;18:161–162
British Cardiovascular Society: Annual Conference 2011 and education plans for 2011-2012
In this sixth article from the British Cardiovascular Society (BCS), Dr Sarah Clarke, BCS Vice-President Education & Research, writes about this year’s Annual Conference and
OBLIQUE VIEW
Br J Cardiol 2011;18:164–66
The Oblique View – Watch your language!
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this column,
CLINICAL ARTICLE
Br J Cardiol 2011;18:189–92
Audit of the NT-ProBNP guided transthoracic echocardiogram service in Southend
Heart failure is one of the most common conditions in industrialised society. Plasma N-terminal prohormone of brain natriuretic peptide (NT-ProBNP) levels are raised in heart